Valuation: OssDsign AB

Market Cap 357M 36.01M 32.07M 29.73M 26.94M 50.67M 3.41B 51.4M 140M 1.79B 135M 132M 5.75B P/E 2026 *
-7.33x
P/E 2027 * -9.08x
Enterprise Value 240M 24.25M 21.6M 20.02M 18.14M 34.12M 2.3B 34.62M 94.29M 1.2B 90.97M 89.07M 3.87B EV / Sales 2026 *
1.53x
EV / Sales 2027 * 1.3x
Free-Float
69.23%
Yield 2026 *
-
Yield 2027 * -
1 day-3.73%
1 week-5.98%
Current month-9.15%
1 month-7.86%
3 months-19.88%
6 months-21.25%
Current year-71.56%
1 week 3.22
Extreme 3.225
3.52
1 month 3.22
Extreme 3.225
3.66
Current year 3.22
Extreme 3.225
11.5
1 year 3.22
Extreme 3.225
13.52
3 years 3.22
Extreme 3.225
16.72
5 years 2.6
Extreme 2.605
16.72
10 years 2.6
Extreme 2.605
26.8
Manager TitleAgeSince
Chief Executive Officer - 2025-12-31
Director of Finance/CFO 63 2019-12-31
Chief Tech/Sci/R&D Officer 47 2021-12-31
Director TitleAgeSince
Chairman 66 2016-04-19
Director/Board Member 60 2021-12-31
Director/Board Member 61 2024-06-24
Date Insider Type Main position Quantity % Market Cap. Importance
11/15/25 Sell

Director

7,000 0.0063%
11/10/25 Buy

Chief Financial Officer

8,000 0.0072%
11/10/25 Buy

Chief Financial Officer

4,640 0.0042%
Change 5-day change 1-year change 3-year change Capi.($)
-3.73%-5.98% - - 37.42M
Average -3.73%
Weighted average by Cap. -3.73%

Financials

2026 *2027 *
Net sales 157M 15.85M 14.12M 13.09M 11.86M 22.31M 1.5B 22.63M 61.63M 786M 59.46M 58.22M 2.53B 231M 23.28M 20.73M 19.22M 17.41M 32.75M 2.21B 33.22M 90.49M 1.15B 87.31M 85.49M 3.71B
Net income -48.35M -4.88M -4.35M -4.03M -3.65M -6.87M -463M -6.97M -18.97M -242M -18.31M -17.92M -779M -38.85M -3.92M -3.49M -3.24M -2.93M -5.52M -372M -5.6M -15.25M -194M -14.71M -14.4M -626M
Net Debt -116M -11.76M -10.47M -9.71M -8.8M -16.55M -1.11B -16.78M -45.72M -583M -44.11M -43.19M -1.88B -56M -5.65M -5.03M -4.67M -4.23M -7.95M -536M -8.07M -21.98M -280M -21.2M -20.76M -902M
Projected Income Statement - Annual - OssDsign AB
Logo OssDsign AB
OssDsign AB, formerly known as Oss-Q AB is a Sweden-based orthopedic medical device company. It aims at developing implantable products that respond to clinical challenges, with focus on bone healing. Its primary focus is skull surgery. The Company uses design solutions, material compositions and manufacturing processes mainly based on proprietary bioceramic technologies. The bioceramics it uses integrate with tissues and support bone ingrowth. OssDsign AB's main product is Craniomosaic, an implant for the repair of skull defects (cranioplasty). Along with it, the Company develops bioceramic implants for facial bone augmentation. The Company's customers include neurosurgeons, craniofacial and maxillofacial surgeons.
Employees
41
Date Price Change Volume
26-10-20 SEK 3.225 -3.73% 67,221
26-10-19 SEK 3.350 +0.30% 131,701
26-10-16 SEK 3.340 0.00% 108,124
26-10-15 SEK 3.340 -2.62% 78,562
26-10-14 SEK 3.430 -0.87% 57,773
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - OssDsign AB

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - OssDsign AB
  1. Stock Market
  2. Stocks
  3. OSSD Stock